5-(AMINOMETHYL)-3-ARYL-2-OXAZOLIDINONES - A NOVEL CLASS OF MECHANISM-BASED INACTIVATORS OF MONOAMINE OXIDASE-B

被引:51
作者
GATES, KS
SILVERMAN, RB
机构
[1] NORTHWESTERN UNIV, DEPT CHEM, EVANSTON, IL 60208 USA
[2] NORTHWESTERN UNIV, DEPT BIOCHEM MOLEC BIOL & CELL BIOL, EVANSTON, IL 60208 USA
关键词
D O I
10.1021/ja00181a044
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The mechanism of inactivation of monoamine oxidase (MAO) by 5-(aminomethyl)-3-aryl-2-oxazolidinones has been investigated. (R)- and (S)-3-[4-[(3-chlorophenyl)methoxy]phenyl]-5-[(methylamino)methyl]-2-oxazolidinone (1) exhibit all of the properties of a mechanism-based inactivator. Several other analogues of 1 also inactivate MAO. Inactivation of MAO by (R)- and (5)-[methoxy-3H]-1 and by [methoxy-3H]-3-(4-methoxyphenyI)-5-[(methylamino)methyl]-2-oxazolidinone (15, R = 3H) led to incorporation of 1.0, 1.2, and 2.1 equiv of tritium per enzyme molecule after denaturation, indicating that a covalent bond between the oxazolidinones and MAO is formed. The partition ratios, determined from the amount of radioactive non-amines generated per tritium incorporated into the enzyme, were 17.6 and 10.9 for the R and 5 isomers, respectively. Inactivation of MAO by (R)- and (S)-[carboxy-14C]-1 resulted in release of 4.5 and 3.0 equiv of 14CO2, respectively. However, in addition to the loss of 14CO2 there also was incorporation of 1.5 and 1.0 equiv of 14C, respectively, into the enzyme after denaturation. The flavin spectrum indicated that the flavin was reduced after inactivation, but upon denaturation the spectrum returned to that of the oxidized form, suggesting that attachment is to an amino acid residue, not to the flavin. 5-(Aminomethyl)-3-(4-cyanophenyl)-2-oxazolidinone inactivates MAO at a rate comparable to or faster than does the corresponding 4-methoxyphenyl analogue, suggesting that there is little or no electronic effect of ring substitution on the rate of inactivation. All of these results support an inactivation mechanism that involves one-electron oxidation of the amine to the amine radical cation, followed by proton removal to give the α radical, which can partition among three pathways (Scheme V): radical combination with an active-site amino acid residue radical to give inactive enzyme, decomposition of the oxazolidinone ring with loss of CO2, and second electron transfer to give the corresponding aldehyde product. © 1990, American Chemical Society. All rights reserved.
引用
收藏
页码:9364 / 9372
页数:9
相关论文
共 52 条
[1]  
ANCHER J F, 1984, Drugs of the Future, V9, P585
[2]   CDNA CLONING OF HUMAN-LIVER MONOAMINE OXIDASE-A AND OXIDASE-B - MOLECULAR-BASIS OF DIFFERENCES IN ENZYMATIC-PROPERTIES [J].
BACH, AWJ ;
LAN, NC ;
JOHNSON, DL ;
ABELL, CW ;
BEMBENEK, ME ;
KWAN, SW ;
SEEBURG, PH ;
SHIH, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (13) :4934-4938
[3]   MECHANISM OF INACTIVATION OF MONOAMINE OXIDASE-B BY (AMINOMETHYL)TRIMETHYLSILANE [J].
BANIK, GM ;
SILVERMAN, RB .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1990, 112 (11) :4499-4507
[4]   A MONOAMINE OXIDASE-B INHIBITOR, MD-780236, METABOLIZED ESSENTIALLY BY THE A-FORM OF THE ENZYME IN THE RAT [J].
BENEDETTI, MS ;
DOW, J .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1983, 35 (04) :238-245
[5]   MONOAMINE-OXIDASE, BRAIN AGING AND DEGENERATIVE DISEASES [J].
BENEDETTI, MS ;
DOSTERT, P .
BIOCHEMICAL PHARMACOLOGY, 1989, 38 (04) :555-561
[6]  
BENEDETTI MS, 1988, PROG DRUG METAB, V11, P149
[7]  
BENEDETTI MS, 1983, Patent No. 3320394
[8]   [H-3] RO-19-6327 - A REVERSIBLE LIGAND AND AFFINITY LABELING PROBE FOR MONOAMINE OXIDASE-B [J].
CESURA, AM ;
GALVA, MD ;
IMHOF, R ;
KYBURZ, E ;
PICOTTI, GB ;
DAPRADA, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 162 (03) :457-465
[9]   [H-3]RO 16-6491, A SELECTIVE PROBE FOR AFFINITY LABELING OF MONOAMINE-OXIDASE TYPE-B IN HUMAN-BRAIN AND PLATELET MEMBRANES [J].
CESURA, AM ;
IMHOF, R ;
TAKACS, B ;
GALVA, MD ;
PICOTTI, GB ;
DAPRADA, M .
JOURNAL OF NEUROCHEMISTRY, 1988, 50 (04) :1037-1043
[10]  
CHUANG HYK, 1974, J BIOL CHEM, V249, P2381